AU6632094A - Enhanced triple-helix and double-helix formation with oligomers containing modified purines - Google Patents

Enhanced triple-helix and double-helix formation with oligomers containing modified purines

Info

Publication number
AU6632094A
AU6632094A AU66320/94A AU6632094A AU6632094A AU 6632094 A AU6632094 A AU 6632094A AU 66320/94 A AU66320/94 A AU 66320/94A AU 6632094 A AU6632094 A AU 6632094A AU 6632094 A AU6632094 A AU 6632094A
Authority
AU
Australia
Prior art keywords
helix
double
containing modified
oligomers containing
modified purines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66320/94A
Other languages
English (en)
Inventor
Brian Froehler
Mark Matteucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AU6632094A publication Critical patent/AU6632094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU66320/94A 1993-04-19 1994-04-12 Enhanced triple-helix and double-helix formation with oligomers containing modified purines Abandoned AU6632094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5069893A 1993-04-19 1993-04-19
US050698 1993-04-19
PCT/US1994/004013 WO1994024144A2 (en) 1993-04-19 1994-04-12 Enhanced triple-helix and double-helix formation with oligomers containing modified purines

Publications (1)

Publication Number Publication Date
AU6632094A true AU6632094A (en) 1994-11-08

Family

ID=21966852

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66320/94A Abandoned AU6632094A (en) 1993-04-19 1994-04-12 Enhanced triple-helix and double-helix formation with oligomers containing modified purines

Country Status (3)

Country Link
EP (1) EP0695306A1 (de)
AU (1) AU6632094A (de)
WO (1) WO1994024144A2 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502177A (en) 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
US6150510A (en) * 1995-11-06 2000-11-21 Aventis Pharma Deutschland Gmbh Modified oligonucleotides, their preparation and their use
DE4438918A1 (de) 1994-11-04 1996-05-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
US5734040A (en) * 1996-03-21 1998-03-31 University Of Iowa Research Foundation Positively charged oligonucleotides as regulators of gene expression
US6274313B1 (en) 1996-03-21 2001-08-14 Pioneer-Hybrid International, Inc. Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use
US6331617B1 (en) 1996-03-21 2001-12-18 University Of Iowa Research Foundation Positively charged oligonucleotides as regulators of gene expression
US6312897B1 (en) 1996-07-03 2001-11-06 President And Fellows Of Harvard College Template-directed interference footprinting of protein-adenine contacts
USRE44779E1 (en) 1997-03-07 2014-02-25 Santaris Pharma A/S Bicyclonucleoside and oligonucleotide analogues
DE19842527A1 (de) * 1998-09-18 2000-03-23 Friedrich Schiller Uni Jena Bu Verfahren zur Bildung tripelhelixbildender Oligomere und deren Verbindungen
US6962906B2 (en) 2000-03-14 2005-11-08 Active Motif Oligonucleotide analogues, methods of synthesis and methods of use
AU2001247414A1 (en) 2000-03-14 2001-09-24 Active Motif Oligonucleotide analogues, methods of synthesis and methods of use
US7070933B2 (en) 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
US7144868B2 (en) 2003-10-27 2006-12-05 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections
EP1687321A1 (de) 2003-10-27 2006-08-09 Genelabs Technologies, Inc. Nukleosidverbindungen zur behandlung viraler infektionen
CA2543116A1 (en) 2003-10-27 2005-05-19 Genelabs Technologies, Inc. Methods for preparing 7-(2'-substituted-.szlig.-d-ribofuranosyl)-4-(nr2r3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
CA2542776A1 (en) 2003-10-27 2005-05-12 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections
US7202223B2 (en) 2003-10-27 2007-04-10 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections
ES2911034T3 (es) 2006-08-08 2022-05-17 Univ Bonn Rheinische Friedrich Wilhelms Estructura y uso de oligonucleótidos 5' fosfato
DK2171088T3 (en) 2007-06-19 2016-01-25 Stratos Genomics Inc Nucleic acid sequencing in a high yield by expansion
WO2009035438A1 (en) * 2007-09-13 2009-03-19 Janos Borbely Polymeric nanoparticles by ion-ion interactions
WO2009141146A1 (en) 2008-05-21 2009-11-26 Gunther Hartmann 5' triphosphate oligonucleotide with blunt end and uses thereof
EP2391726B1 (de) 2009-01-29 2015-09-23 Stratos Genomics Inc. Hochdurchsatz-nukleinsäuresequenzierung mittels expansion und zugehörige verfahren
EP2414359A1 (de) 2009-03-31 2012-02-08 ArQule, Inc. Perikondensierte pyrazolopyrimidinverbindungen
WO2012003330A2 (en) 2010-06-30 2012-01-05 Stratos Genomics, Inc Multiplexed identification of nucleic acid sequences
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
EP2508530A1 (de) 2011-03-28 2012-10-10 Rheinische Friedrich-Wilhelms-Universität Bonn Reinigung von triphosphorylierten Oligonucleotiden mit Einfang-Tags
US9212392B2 (en) 2012-09-25 2015-12-15 Exact Sciences Corporation Normalization of polymerase activity
EP2712870A1 (de) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Neuartige RIG-I-Liganden und Herstellungsverfahren dafür
US20140287946A1 (en) 2013-03-14 2014-09-25 Ibis Biosciences, Inc. Nucleic acid control panels
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
AU2015349730C1 (en) 2014-11-20 2020-04-30 F. Hoffmann-La Roche Ag Nulceoside phosphoroamidate esters and derivatives thereof, use and synthesis thereof
JP7381190B2 (ja) 2014-12-26 2023-11-15 エモリー・ユニバーシテイ Ｎ４－ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
CN108350485A (zh) 2015-10-30 2018-07-31 精密科学发展有限责任公司 血浆dna的多重扩增检测测定以及分离和检测
EP3377648B1 (de) 2015-11-16 2021-01-06 Stratos Genomics, Inc. Dp04-polymerase-varianten
CN109563546B (zh) 2016-05-05 2022-09-09 精密科学发展有限责任公司 通过分析甲基化dna来检测肺肿瘤
KR102892245B1 (ko) 2017-01-27 2025-11-27 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 메틸화된 dna 분석에 의한 결장 신조직형성의 검출
US11708566B2 (en) 2017-05-04 2023-07-25 Stratos Genomics, Inc. DP04 polymerase variants
PT3706762T (pt) 2017-12-07 2024-12-05 Univ Emory N4-hidroxicitidina e derivados e utilizações antivirais relacionadas com os mesmos
CA3084812A1 (en) 2017-12-11 2019-06-20 Stratos Genomics, Inc. Dpo4 polymerase variants with improved accuracy
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
EP4031683A4 (de) 2019-09-16 2024-01-17 Exact Sciences Corporation Struktur- und temperaturabhängige flap-endonukleasesubstrate
GB2605952A (en) * 2021-04-12 2022-10-26 Stealth Labels Biotech Ab Fluorescent nucleoside triphosphates
US20220403450A1 (en) 2021-06-03 2022-12-22 Illumina Software, Inc. Systems and methods for sequencing nucleotides using two optical channels
AU2022303381A1 (en) 2021-07-01 2024-01-18 Illumina, Inc. Device having horizontal nanochannel for nanopore sequencing
EP4396376A1 (de) 2021-09-01 2024-07-10 Illumina, Inc. Amplitudenmodulation für beschleunigten basisanruf
US20230090867A1 (en) 2021-09-22 2023-03-23 Illumina, Inc. Sequencing polynucleotides using nanopores
US12455277B2 (en) 2021-09-30 2025-10-28 Illumina, Inc. Isolation of cells in a nanopore sensor array
US20240319165A1 (en) 2021-11-15 2024-09-26 Illumina, Inc. Nanopore systems and methods of fabrication
US20230183799A1 (en) 2021-12-10 2023-06-15 Illumina, Inc. Parallel sample and index sequencing
AU2023236924A1 (en) 2022-03-15 2024-10-24 Illumina, Inc. Paired-end sequencing
US20230357307A1 (en) 2022-05-04 2023-11-09 Illumina, Inc. Cleavable cyclic loop nucleotides for nanopore sequencing
IL317411A (en) 2022-06-07 2025-02-01 Illumina Inc Methods and systems for identifying gene variants
KR20250036077A (ko) 2022-07-07 2025-03-13 일루미나, 인코포레이티드 카피수 변이체 유전자형을 결정하기 위한 방법 및 시스템
CA3259709A1 (en) 2022-07-07 2024-01-11 Illumina, Inc. METHODS AND SYSTEMS FOR DETECTING RECOMBINATION EVENT
US20260011403A1 (en) 2022-09-26 2026-01-08 Illumina, Inc. Detecting and genotyping variable number tandem repeats
US12529677B2 (en) 2022-09-28 2026-01-20 Illumina, Inc. Fast pulsing for nanopore sensors
US20240257904A1 (en) 2023-01-31 2024-08-01 Illumina, Inc. Copy number variant calling and recovery
JP2026509693A (ja) 2023-03-10 2026-03-25 イルミナ インコーポレイテッド ポリヌクレオチド配列をアセンブルするためのｋ－ｍｅｒベースの方法
KR20260008092A (ko) 2023-05-03 2026-01-15 일루미나, 인코포레이티드 나노포어 시퀀싱에서의 제어된 폴리뉴클레오티드 전위
EP4735634A1 (de) 2023-06-30 2026-05-06 Illumina, Inc. Systeme und verfahren zur sequenzierung von polynukleotiden mit modifizierten basen
EP4735636A1 (de) 2023-06-30 2026-05-06 Illumina, Inc. Systeme und verfahren zur sequenzierung von polynukleotiden mit vier markierten nukleotiden
EP4735635A1 (de) 2023-06-30 2026-05-06 Illumina, Inc. Systeme und verfahren zur sequenzierung von polynukleotiden mit alternativen scatterplots
WO2025061922A1 (en) 2023-09-20 2025-03-27 Illumina, Inc. Methods for sequencing
WO2025061942A1 (en) 2023-09-20 2025-03-27 Illumina, Inc. Sequencing error identification and correction
US20250109433A1 (en) 2023-09-22 2025-04-03 Illumina, Inc. Macromolecule blocks for nanopore sequencing
WO2025072861A1 (en) 2023-09-29 2025-04-03 Illumina, Inc. Cleavable cyclic loop nucleotides for nanopore sequencing
WO2025072468A1 (en) 2023-09-29 2025-04-03 Illumina, Inc. Methods and systems for estimating copy numbers and detecting variants
WO2025072047A1 (en) 2023-09-29 2025-04-03 Illumina, Inc. Methods and systems for determining a cyp2a6 genotype
WO2025082960A1 (en) 2023-10-18 2025-04-24 F. Hoffmann-La Roche Ag Dpo4 polymerase variants with improved properties
WO2025149479A1 (en) 2024-01-12 2025-07-17 Roche Diagnostics Gmbh Synthesis of modified nucleoside triphosphates
WO2025149478A1 (en) 2024-01-12 2025-07-17 F. Hoffmann-La Roche Ag Compositions of modified nucleoside triphosphates
WO2025159980A1 (en) 2024-01-23 2025-07-31 Illumina, Inc. Ratchet-chelators as unique barcodes for nanopore sequencing
WO2025174660A1 (en) 2024-02-12 2025-08-21 Illumina, Inc. Recharging for nanopore system
WO2025174659A1 (en) 2024-02-12 2025-08-21 Illumina, Inc. Net-zero current scheme for nanopore system
WO2025183909A1 (en) 2024-03-01 2025-09-04 Illumina, Inc. Ribose-mediated cyclic loop opening for nanopore sequencing
WO2025184183A1 (en) 2024-03-01 2025-09-04 Illumina, Inc. Designer peptide cyclic loops for nanopore sequencing
WO2025190902A1 (en) 2024-03-13 2025-09-18 Illumina, Inc. Improving base calling quality scores
WO2025245014A1 (en) 2024-05-24 2025-11-27 Illumina, Inc. Nuclease assisted nanopore sequencing
WO2025250322A1 (en) 2024-05-31 2025-12-04 Illumina, Inc. Genotyping for tandem repeats
WO2025254714A1 (en) 2024-06-03 2025-12-11 Illumina, Inc. System and method for assembling a polynucleotide sequence
WO2026043922A1 (en) 2024-08-21 2026-02-26 Illumina, Inc. Modified nucleotides and related methods for nanopore sequencing
US20260085352A1 (en) 2024-09-26 2026-03-26 Illumina, Inc. Pulsed recharging for nanopore devices
WO2026072464A1 (en) 2024-09-27 2026-04-02 Illumina, Inc. Read mapping enhanced by spatial information

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337530A (en) * 1965-09-20 1967-08-22 Upjohn Co Dinucleoside 3', 5' -and 2', 5'-phosphates containing one 7-deazapurin riboside moiety
US3309358A (en) * 1965-09-20 1967-03-14 Upjohn Co 7-deazaadenine 2', 5'-and 3', 5'-dinucleoside phosphate and process therefor
US3962211A (en) * 1975-01-13 1976-06-08 The University Of Utah 7-substituted nucleoside compounds
PT71393B (en) * 1979-06-14 1981-10-22 Wellcome Found Antiprotozoal agents
US4352795A (en) * 1981-01-29 1982-10-05 Warner-Lambert Company 7-β-D-Arabinofuranosyl-7H-pyrrolo[2,3-d]pyrimidine compounds and methods for their production
US5047519A (en) * 1986-07-02 1991-09-10 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
DE3739366A1 (de) * 1987-04-10 1988-10-27 Boehringer Mannheim Gmbh Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
DE68929321T2 (de) * 1988-06-09 2002-05-08 Temple University Of The Commonwealth System Of Higher Education, Philadelphia Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten
WO1990003370A1 (en) * 1988-09-28 1990-04-05 Microprobe Corporation DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE
EP0450102A4 (en) * 1989-10-26 1992-05-06 Yamasa Shoyu Kabushiki Kaisha Nucleoside derivative
WO1993003736A1 (en) * 1991-08-21 1993-03-04 Microprobe Corporation Cross-linking oligonucleotides for enzyme-mediated triple strand formation
WO1993009127A1 (en) * 1991-11-07 1993-05-13 Gilead Sciences, Inc. Enhanced triple-helix formation directed by oligonucleotides composed of 2'-deoxy-7-deazaxanthosine and 2'-deoxy-7-deazaguanosine and related analogs
DE4140463A1 (de) * 1991-12-09 1993-06-17 Boehringer Mannheim Gmbh 2'-desoxy-isoguanosin, dessen isostere analoge sowie anwendung derselben

Also Published As

Publication number Publication date
EP0695306A1 (de) 1996-02-07
WO1994024144A2 (en) 1994-10-27
WO1994024144A3 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
AU6632094A (en) Enhanced triple-helix and double-helix formation with oligomers containing modified purines
AU3201993A (en) Personal computer system with security features and method
AU5246096A (en) Polygonal information encoding article, process and system
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
AU3429789A (en) Antipilferage tags and their use
GB2279784B (en) Data acquisition and processing system
ZA893176B (en) Fluoroavermectin and fluoromilbemycin derivatives with antiparasitic and presticidal properties
AU4313993A (en) Card-shaped information carrier and its use
EP0551865A3 (en) Polycarbonate and use thereof
AU4747090A (en) Security and alarm system
AU7477094A (en) Hair penetrant and carrier
AU1764292A (en) Re-catalyst and carrier
GB2251773B (en) Graphics accelerator system with line drawing and tracking operations
AU647625B2 (en) Transporter with function of maintaining and moving centre of gravity
AU4843293A (en) 3-azidomethyl-3-nitratomethyloxetane and polymers formed therefrom
AU4351693A (en) Carrier and spacer
EP0667521A4 (de) Biochemischer sauerstoffbedarfsensor und verfahren zum messen des biochemischen sauerstoffbedarf.
AU1379788A (en) Polyethylene terephthalate and uses thereof
AU5656994A (en) Chiral arylpropionates and their use
AU111792S (en) Bottle and cap
AU7692394A (en) Phosphinic acid derivatives with anti-hyper glycemic and/or anti-obesity activity
IL118381A0 (en) Solutions containing erythromycylamine and their use
AU676770C (en) Cyclic peptide with higher stability and/or higher activity
AU7665994A (en) Cyclic peptide with higher stability and/or higher activity
AU7801594A (en) Boronated metalloporphyrins and therapeutic methods